US Patent Issued to Nanjing Hanxin Pharmaceutical Technology on Oct. 7 for "High-purity adrenocorticotropic hormone analogue and a large-scale preparation method thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,433,936, issued on Oct. 7, was assigned to Nanjing Hanxin Pharmaceutical Technology Co. Ltd. (Nanjing, China).

"High-purity adrenocorticotropic hormone analogue and a large-scale preparation method thereof" was invented by Jundong Meng (Nanjing, China), Tao Yang (Nanjing, China), Feifei Wu (Nanjing, China) and Haoning Zhang (Nanjing, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Polypeptide preparation methods of preparing high-purity ACTH (human sequence) or analogue and large-scale preparation method thereof are described. The main steps include: amino acids are coupled from the C-terminal to the N-terminal by Fmoc solid-phase synthesis method t...